Kerri Beckmann

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Venues

The Prostate

Genetic epidemiology

BJUI compass

Prostate cancer and prostatic diseases

University of South Australia Sansom Institute for Health Research

University of Adelaide (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of South Australia Sansom Institute for Health Research Aug 04 2014

Australia

Research Fellow :: Cancer Epidemiology and Population Health

Education History

University of Adelaide Mar 26 2011 - Dec 18 2014

Australia

PHD :: Population Health

Publications

Tenaw Yimer Tiruye, David Roder, Liesel M FitzGerald, Michael O'Callaghan, Kim Moretti, Gillian E Caughey, Kerri Beckmann
Impact of comorbidities on prostate cancer-specific mortality: A population-based cohort study. The Prostate (2024)
Tenaw Yimer Tiruye, Mrunal Hiwase, Megan Charlick, Michael O'Callaghan, Ashna Khalid, Ming Li, Liesel M FitzGerald, Gillian E Caughey, Kerry Ettridge, David M Roder, Kerri Beckmann
Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer. Psycho-oncology 33 (7) (2024)
Tenaw Yimer Tiruye, David Roder, Liesel M FitzGerald, Michael O'Callaghan, Kim Moretti, Gillian E Caughey, Kerri Beckmann
Impact of comorbidities on prostate cancer-specific mortality: A population-based cohort study. The Prostate 84 (12) (2024)
Wee Loon Ong, Krupa Krishnaprasad, Jonathan G Bensley, Michelle Steeper, Kerri Beckmann, Sibilah Breen, Michelle King, Stephen Mark, Michael E O'Callaghan, Manish Patel, Emma Tod, Jeremy L Millar, null null
Population-based prostate cancer outcomes registries - what have we learned and where are we heading? BJU international (2024)
Dovini Jayasinghe, Md Moksedul Momin, Kerri Beckmann, Elina Hyppӧnen, Beben Benyamin, Sang Hong Lee
Mitigating type 1 error inflation and power loss in GxE PRS: Genotype-environment interaction in polygenic risk score models. Genetic epidemiology 48 (2) (2024)
Dovini Jayasinghe, Md Moksedul Momin, Kerri Beckmann, Elina Hyppӧnen, Beben Benyamin, Sang Hong Lee
Mitigating type 1 error inflation and power loss in GxE PRS: Genotype-environment interaction in polygenic risk score models. Genetic epidemiology (2024)
Megan Charlick, Tenaw Yimer Tiruye, Kerry Ettridge, Michael O'Callaghan, Sally Am Sara, Alexander Jay, Kerri Beckmann
Prostate Cancer Related Sexual Dysfunction and Barriers to Help Seeking: A Scoping Review. Psycho-oncology 33 (8) (2024)
Dovini Jayasinghe, Md Moksedul Momin, Kerri Beckmann, Elina Hyppӧnen, Beben Benyamin, Sang Hong Lee
Mitigating type 1 error inflation and power loss in GxE PRS: Genotype-environment interaction in polygenic risk score models. Genetic epidemiology 48 (2) (2024)
Dovini Jayasinghe, Md Moksedul Momin, Kerri Beckmann, Elina Hyppӧnen, Beben Benyamin, Sang Hong Lee
Mitigating type 1 error inflation and power loss in GxE PRS: Genotype-environment interaction in polygenic risk score models. Genetic epidemiology 48 (2) (2024)
Tenaw Yimer Tiruye, Michael E O'Callaghan, Kerry A Ettridge, Kim Moretti, Alex Jay, Braden Higgs, Kerry Santoro, Ganessan Kichenadasse, Kerri Beckmann
Clinical and functional outcomes for risk-appropriate treatments for prostate cancer. BJUI compass 5 (1) (2023)
Tenaw Yimer Tiruye, Michael O'Callaghan, Kerry Ettridge, Alex Jay, Kerry Santoro, Kim Moretti, Kerri Beckmann
Factors impacting on sexual function among men on active surveillance for prostate cancer. The Prostate (2023)
Tenaw Yimer Tiruye, Michael E O'Callaghan, Kerry A Ettridge, Kim Moretti, Alex Jay, Braden Higgs, Kerry Santoro, Ganessan Kichenadasse, Kerri Beckmann
Clinical and functional outcomes for risk-appropriate treatments for prostate cancer. BJUI compass 5 (1) (2023)
Tenaw Yimer Tiruye, Michael O'Callaghan, Kerry Ettridge, Alex Jay, Kerry Santoro, Kim Moretti, Kerri Beckmann
Factors impacting on sexual function among men on active surveillance for prostate cancer. The Prostate (2023)
Kerri Beckmann, Aida Santaolalla, Mikio Sugimoto, Peter Carroll, Jose Rubio, Arnauld Villers, Anders Bjartell, Todd M Morgan, Prokar Dasgupta, Mieke Van Hemelrijck, Oussama Elhage, null null
Risk of progression following a negative biopsy in prostate cancer active surveillance. Prostate cancer and prostatic diseases (2022)
Kerri Beckmann, Declan Cahill, Christian Brown, Mieke Van Hemelrijck, Netty Kinsella
Developing a consensus statement for psychosocial support in active surveillance for prostate cancer. BJUI compass 4 (1) (2022)
Kerri Beckmann, Danielle Crawley, William G Nelson, Elizabeth A Platz, Elizabeth Selvin, Mieke Van Hemelrijck, Sabine Rohrmann
Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer. Cancer causes & control : CCC 33 (3) (2022)
Kerri Beckmann, Brendon J Kearney, David Yeung, Devendra Hiwase, Ming Li, David M Roder
Changes in five-year survival for people with acute leukaemia in South Australia, 1980-2016. The Medical journal of Australia 216 (6) (2022)
Kerri Beckmann, Declan Cahill, Christian Brown, Mieke Van Hemelrijck, Netty Kinsella
Developing a consensus statement for psychosocial support in active surveillance for prostate cancer. BJUI compass 4 (1) (2022)
Kerri Beckmann, Sudarshan Selva-Nayagam, Ian Olver, Caroline Louise Miller, Elizabeth S Buckley, Kate Powell, Dianne Buranyi-Trevarton, Raghu Gowda, David Roder, Martin K Oehler
Carcinosarcomas of the Uterus: Prognostic Factors and Impact of Adjuvant Treatment. Cancer management and research 13 (2021)
Rebecca K Bott, Kerri Beckmann, Janine Zylstra, Michelle J Wilkinson, William R C Knight, Cara R Baker, Mark Kelly, Nick Maisey, Justin Waters, Mieke Van Hemelrijck, Elizabeth C Smyth, William H Allum, Jesper Lagergren, James A Gossage, David Cunningham, Andrew R Davies
Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins. Acta oncologica (Stockholm, Sweden) 60 (5) (2021)
Francesca Kum, Kerri Beckmann, Haleema Aya, Sohail Singh, Preeti Sandhu, Sukhmani Sra, Jonah Rusere, Grace Zisengwe, Aida Santaolalla, Paul Cathcart, Ben Challacombe, Christian Brown, Rick Popert, Prokar Dasgupta, Mieke Van Hemelrijck, Oussama Elhage
Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre. Prostate cancer and prostatic diseases 24 (2) (2021)
Maria Jose Monroy-Iglesias, Beth Russell, Danielle Crawley, Naomi E Allen, Ruth C Travis, Aurora Perez-Cornago, Mieke Van Hemelrijck, Kerri Beckmann
Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank. International journal of cancer 148 (4) (2020)
Kerri Beckmann, Hans Garmo, Bertil Lindahl, Lars Holmberg, Pär Stattin, Jan Adolfsson, J Kennedy Cruickshank, Mieke Van Hemelrijck
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study. Prostate cancer and prostatic diseases 23 (3) (2020)
Sohail Singh, Preeti Sandhu, Kerri Beckmann, Aida Santaolalla, Kamal Dewan, Sharon Clovis, Jonah Rusere, Grace Zisengwe, Benjamin Challacombe, Christian Brown, Paul Cathcart, Rick Popert, Prokar Dasgupta, Mieke Van Hemelrijck, Oussama Elhage
Negative first follow-up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatment. BJU international 128 (1) (2020)
Kerri Beckmann, Hans Garmo, Per Nilsson, Ingela Franck Lissbrant, Anders Widmark, Pär Stattin
Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016. Acta oncologica (Stockholm, Sweden) 59 (5) (2020)
Kerri Beckmann, Netty Kinsella, Henrik Olsson, Anna Wallerstedt Lantz, Tobias Nordstrom, Markus Aly, Jan Adolfsson, Martin Eklund, Mieke Van Hemelrijck
Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer? BMC urology 19 (1) (2019)
Kerri Beckmann, Beth Russell, Debra Josephs, Hans Garmo, Christel Haggstrom, Lars Holmberg, Pär Stattin, Mieke Van Hemelrijck, Jan Adolfsson
Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study. BMC cancer 19 (1) (2019)

Kerri Beckmann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kerri Beckmann